SlideShare a Scribd company logo
1 of 29
Download to read offline
Merck KGaA
Darmstadt, Germany
Mary Robinette and Elizabeth Goodrich
September 26, 2019
Using Single-use
Technology to
Overcome the
Challenges of ADC
Processing
2
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 2019
The life science business of
Merck KGaA, Darmstadt, Germany
operates as MilliporeSigma
in the U.S. and Canada.
Agenda
01 The Case for Using Single-use Equipment in
ADC Processes
02 Single-use Component Compatibility Testing
03 ADC Single-use cGMP Production - Lessons
Learned
04 Conclusions
3
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 2019
The Case for
Single-use in ADC
Processes
01
5
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 2019
Single-use Technology to Streamline Bioprocessing
Speed
Safety
Process
Economics
Flexibility
 Faster product changeover
 Accelerated time to clinic
or market
 Faster implementation
 Eliminates cleaning
Validation
 Reduced bioburden risks
 Reduced cross-
contamination risks
 Reduced operator and
environment exposure
 Adaptability to changing
process needs
 Multi-product
manufacturing facilities
 Scalable and movable
platforms
 Lower cost: reduced water/caustics,
utilities, equipment downtime, and
unproductive labor
 Compact footprint
 Lower investment
6
Applicability of Single-use Technology for ADCs
 Process capability for ADC
processes
 Compatibility/Extractable Studies
including ADC solvents
 Single Use Assembly Testing
− Leak testing
− Class VI USP
 Product Specific Testing
− BioReliance® Extractable and
Leachable Validation Services
Solvent Component
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 2019
Single-use ADC Process
7 Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 20197
Reaction
Mobius® Mix
10-1000L
UF/DF
Mobius® FlexReady
TF2, TF3 2-10m2
Chromatography
Mobius® FlexReady
0.1 – 8LPM
Formulation/ Filtration
Mobius® Mix and Filters
10-1000L
Filtration
Opticap® Filter with Millipore Express®
SHC membrane
UF/DF
Mobius® FlexReady TF2,TF3
0.5-10m2
Solvent Component
8 Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 2019
Solvent Compatibility Considerations
 Solvent composition
 Product contact components
 Performance testing
− Visual inspection for leaks and physical changes
− Functionality testing
− Sterile filters – verify microbial retention
− Extractables
ADC Single-use Process – Solvent Compatibility
T
Mobius® FlexReady Solution
with Smart Flexware®
Assemblies
Common ADC Process Solvents
 Drug charge to reactor:
− 100% DMSO (Dimethyl Sulfoxide)
− 100% DMAc (Dimethyl Acetamide)
 Reaction/Purification composition
− up to 20% DMSO
− up to 20% DMAc
ADC Single-use Process – Solvent Composition
Mobius® Single-use Jacketed
Mix 100 L
9 Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 2019
ADC Single-use Reactor – Solvent Compatibility
Mix bag components
 Bag film
 Ports
 Mixer
 Tubing
 Sampling valve
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201910
Mixer
Sampling
Mobius® MyWay
50L PureFlex™ Mobius® MIX Bag
Ports
Film
Example Mix Bag Components
PureFlex™ Film
Risk assess component exposure to 100% solvent
Flow path assembly components
 Pump
 Valves
 Instrumentation
 Mix bag
 Sampling
ADC Purification Equipment – Solvent Compatibility
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201911
Recovery Line
To Transfer Pump
Smart Flexware® Assembly for TFF
100L Single-use
Feed Container
Assembly
Filtrate Assembly with
Single-use Sensors Flow Cell
Retentate Sampling
Port Assembly
Dow Corning® Pharma-80 Tubing,
used to create bypass loop around TFF
liners and cassettes
Extractable Test Setup on Mobius® FlexReady Solution
with Smart Flexware® Assemblies for TFF
Single-use Feed
Pump Assembly
Test Setup on Mobius® FlexReady Solution with Smart
Flexware® Assemblies for TFF
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 2019
Single-use
Component
Compatibility
Testing
02
After exposure to:
 20% and 100% Dimethyl Sulfoxide
(DMSO)
 20% and 100% Dimethyl Acetamide
(DMAc)
 Water
Provide understanding on compatibility of selected standard single-use assemblies and
components with the solvents most commonly used in ADC processing
Overview of Compatibility Testing
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201913
Evaluate functionality and extractables of:
 Mobius® MIX bag made from PureFlex™
film
 Opticap® XL filter with Millipore Express®
SHC membrane
 Mobius® FlexReady Solution with SMART
Flexware® assemblies for TFF or
Chromatography
 Lynx® CDR and Lynx® S2S sterile
connectors
 Colder AseptiQuik® G sterile connectors
PureFlex™ film
 100% DMSO, 100% DMAc, RO water
 24-hour soak in solvent at 40°C
Post-solvent exposure:
 No visual changes
 No change in bag seam strength
 Slight increase in film elongation at break
− No negative performance impact
expected
− In use, bag is supported in a holder
Mobius® MIX bag testing
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201914
Millipore Express® SHC 0.5 mm / 0.2 mm PES
membrane
 47 mm membrane discs and 5” Opticap® XLT
capsule
 20% DMSO, 20% DMAc, RO water
 24-hour soak in solvent at 40°C
Post-solvent exposure:
 No visual or physical changes
 Water flow passes specification
 Bubble point passes specification
 Capsule maintains complete microbial
retention (> 9 log reduction of B. diminuta)
Millipore Express® SHC membrane and Opticap® Filter Capsule testing
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201915
ADC Processing using Millipore Express® SHC
(Cat#KHGEG015FF3/Lot#C8DA57941)
Bacterial Retention Test
(B. diminuta;>107 CFU/cm2)
Opticap® Filter with Millipore Express® SHC Extractables Evaluation
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201916
 No pre-use flush of capsule
 All identified components are from membrane
manufacture or gamma irradiation
 In a worse-case process scenario with low
filter throughput (150 L/m2), all extractable
components would be < 0.1 mg/mL in pool
 Subsequent diafiltration will reduce even more
Opticap® XL5 Capsule with Millipore Express® SHC Membrane
Non-Volatile Extractables via HPLC-DAD/MS
Opticap® XL5 Capsule with Millipore Express® SHC Membrane
Semi-Volatile Extractables via DI-GC/MS Opticap® XL5 Capsule with Millipore Express® SHC Membrane
Volatile Extractables via HS-GC/MS
Flow Paths and Wetted Materials for Solvent Exposure Testing
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201917
Recovery Line
To Transfer Pump
Smart Flexware® Assembly for TFF
100L Single-use
Feed Container
Assembly
Filtrate Assembly with
Single-use Sensors Flow Cell
Retentate Sampling
Port Assembly
Dow Corning® Pharma-80 Tubing,
used to create bypass loop around TFF
liners and cassettes
Extractable Test Setup on Mobius® FlexReady Solution
with Smart Flexware® Assemblies for TFF
Single-use Feed
Pump Assembly
Lynx® Connectors Flow Loop AseptiQuik® G Flow Loop
Extractable Test Setup on Mobius ® FlexReady Solution
with Smart Flexware® Assemblies for TFF
Flowpaths for Post-Exposure Functional Testing
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201918
Valve Bypass Test setup #1
Valve Bypass Test setup #2
Valve Cycling Test setup
Metals Analysis
 Only traces of sodium and calcium were detected
 No metals identified are classified as elements to be considered in the risk assessment as outlined in
ICH Q3D Guideline for Elemental Impurities and USP <232> Elemental Impurities
Non-Volatile Organic Analysis
 No compounds were detected in any system or solvent combination using LC-MS analysis.
Volatile Organic Analysis
 HS-GC/MS analysis for volatile organic compounds indicated no extractable peaks in any system.
Semi-Volatile Organic Analysis
 DI-GC/MS analysis for semi-volatile organic compounds did not identify any peaks above 0.05 mg/mL.
 Results from DMAc exposure, shown on next slide, represent the highest observed levels of the three
solutions which were tested.
Mobius® Smart Flexware™ and Lynx® Connector Extractables
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201919
Extractables after Exposure to 20% DMAc
Smart Flexware® Assemblies and Connectors for Mobius®
systems, Method: DI-GC/MS
1 Mobius® TF-2S Smart Flexware® assembly, 6L recirculation
Extractables after Exposure to 20% DMAc: Direct Inject GC-MS
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201920
Extractables after Exposure to 20% DMAc
Smart Flexware® Assemblies and Connectors for Mobius®
systems, Method: DI-GC/MS
All identified compounds are < 0.05 mg/mL
1 TF-2S Smart Flexware® Assembly, 6L recirculation
1 Lynx® CDR and 1 Lynx® S2S, 0.5L recirculation
2 AseptiQuick® G connectors, 0.5L recirculation
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 2019
ADC Single-use cGMP
Production –
Lessons Learned
03
 Single-use system design/suitability review:
end user and supplier
− User requirements collaboration session
− Proper selection of standard systems and
options
− Review options for single-use assembly
custom design
− Users attend supplier demonstration of single-
use equipment
− Outcome: optimal single use-system for
application
 Supplier training for production success
− Single-use system hardware
− Single-use assembly unpacking and installation
− Key to prevent single use assembly damage
ADC Single-use End-user / Supplier Collaboration for Success
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201922
Mobius® Single-use Jacketed Mixers
M Lab™ Burlington, MA
Single-use Technology Benefits - ADC Production experience
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201923
Speed
Safety
Process
Economics
Flexibility
 Faster product changeover
 Accelerated time to clinic
or market
 Faster implementation
 Eliminates cleaning
Validation
 Reduced bioburden risks
 Reduced cross-contamination
risks
 Reduced operator and
environment exposure
 Adaptability to changing
process needs
 Multi-product
manufacturing facilities
 Scalable and movable
platforms
 Lower cost: reduced
water/caustics, utilities, equipment
downtime, and unproductive labor
 Compact footprint
 Lower investment
Reduced ADC potent
waste handling/disposal
Platform ADC process equipment
 Standard automated hardware and single use
flowpath assemblies
− Examples: Chromatography and TFF skids, mix
bags
 Development of standards for custom designed
single use assemblies - multiple product/process
application
− Examples:
− Bag manifolds with pump tubing, sample bag
and filter in one single use assembly
− Mix bag assemblies for ADC reactor, process
blending and formulation
 Additional benefits
− Simplified inventory
− Reduce operator training/manual intervention
− Reduce autoclave parts
ADC Single-use - Production Experience
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201924
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 2019
Conclusions
04
 Demonstrated solvent compatibility of the most commonly used ADC conjugation chemicals at
conditions that exceed typical concentrations and exposure times for:
− Mobius® Mix bag with PureFlex™ film
− Opticap® XL filter with Millipore Express® SHC membrane
− Mobius® FlexReady Solution with Smart Flexware® Assemblies for TFF or Chromatography
− Mobius Lynx® CDR, Mobius Lynx® S2S Connectors and Colder AseptiQuik® G sterile connectors
 After 24 Hour exposure to 20% DMSO or 20% DMAc
− No leaks and no physical changes observed by visual inspection
− Bags, flexware, connectors, and filters passed all functionality testing including microbial retention
− PureFlex™ film maintained performance after 24-hour exposure to 100% DMSO or 100% DMAc
 Extractables Profile
− No peaks were identified by LC-MS or HS GC-MS for any of the solvent extractions.
− Several peaks were visible using DI GC-MS. No compounds were present above 0.05 mg/mL.
− No metals identified by ICP that are classified as elements to be considered in the risk assessment
per ICH Q3D Guideline for Elemental Impurities and USP <232> Elemental Impurities
Conclusions: Compatibility and Extractables
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201926
 A broad range of single-use equipment is available to
meet the challenging needs of ADC production.
 Single-use assemblies are compatible with ADC process
solutions.
 Single-use supplier and end user collaboration is key
for successful process application.
 Single-use equipment benefits are realized in ADC
production.
 Use of standard and custom single-use systems allows
for an ADC process equipment platform that meets
multiple product/process needs.
Conclusions: Single-use Application for ADC Process
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201927
Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201928
Acknowledgements
Compatibility and Extractables Testing Team:
Dana Kinzlmaier
Jessica Shea
Shannon Ryan
Venkata Raman
Alex Chalmers
Brian Callahan
Shikeba Shirzay
Mobius® Technical support
 R&D
 Applications Engineering
 Bioprocessing
Bio-Conjugation Center of Excellence St. Louis
 Global Process & Analytical Development
 ADC Production manufacturing
Director of MSAT Applications
Engineering
Email:
Elizabeth.Goodrich@milliporesigma.com
Principal Project Engineer, API Global
Engineering
Email:
Mary.Robinette@milliporesigma.com
Elizabeth GoodrichMary Robinette
The vibrant M, SAFC, Mobius, Lynx, Opticap, Millipore Express, Emprove, Flexware and PureFlex are trademarks of Merck KGaA, Darmstadt, Germany or its affiliates. All other
trademarks are the property of their respective owners. Detailed information on trademarks is available via publicly accessible resources.
© 2019 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.
Thank you!

More Related Content

What's hot

Process development guidance for AAV and lentivirus manufacturing based on co...
Process development guidance for AAV and lentivirus manufacturing based on co...Process development guidance for AAV and lentivirus manufacturing based on co...
Process development guidance for AAV and lentivirus manufacturing based on co...
MilliporeSigma
 
Beyond Bioprocessing 4.0: The Convergence of IT, OT and Processing Technolog...
Beyond Bioprocessing 4.0:  The Convergence of IT, OT and Processing Technolog...Beyond Bioprocessing 4.0:  The Convergence of IT, OT and Processing Technolog...
Beyond Bioprocessing 4.0: The Convergence of IT, OT and Processing Technolog...
Merck Life Sciences
 
Aseptic Process Sampling to address Risk of Contamination & Containment in co...
Aseptic Process Sampling to address Risk of Contamination & Containment in co...Aseptic Process Sampling to address Risk of Contamination & Containment in co...
Aseptic Process Sampling to address Risk of Contamination & Containment in co...
MilliporeSigma
 
Facility Intensification and Cost Reduction using an Integrated Buffer Delive...
Facility Intensification and Cost Reduction using an Integrated Buffer Delive...Facility Intensification and Cost Reduction using an Integrated Buffer Delive...
Facility Intensification and Cost Reduction using an Integrated Buffer Delive...
Merck Life Sciences
 
Hot melt extrusion with PVA: A new opportunity for challenging APIs
Hot melt extrusion with PVA: A new opportunity for challenging APIs Hot melt extrusion with PVA: A new opportunity for challenging APIs
Hot melt extrusion with PVA: A new opportunity for challenging APIs
Merck Life Sciences
 

What's hot (15)

Webinar: How to Develop a Regulatory-compliant Continued Process Verificatio...
Webinar: 	How to Develop a Regulatory-compliant Continued Process Verificatio...Webinar: 	How to Develop a Regulatory-compliant Continued Process Verificatio...
Webinar: How to Develop a Regulatory-compliant Continued Process Verificatio...
 
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
 
Potential Impact of Draft Annex 1 on Sterilizing Filtration
Potential Impact of Draft Annex 1 on Sterilizing FiltrationPotential Impact of Draft Annex 1 on Sterilizing Filtration
Potential Impact of Draft Annex 1 on Sterilizing Filtration
 
Process development guidance for AAV and lentivirus manufacturing based on co...
Process development guidance for AAV and lentivirus manufacturing based on co...Process development guidance for AAV and lentivirus manufacturing based on co...
Process development guidance for AAV and lentivirus manufacturing based on co...
 
Beyond Bioprocessing 4.0: The Convergence of IT, OT and Processing Technolog...
Beyond Bioprocessing 4.0:  The Convergence of IT, OT and Processing Technolog...Beyond Bioprocessing 4.0:  The Convergence of IT, OT and Processing Technolog...
Beyond Bioprocessing 4.0: The Convergence of IT, OT and Processing Technolog...
 
Aseptic Process Sampling to address Risk of Contamination & Containment in co...
Aseptic Process Sampling to address Risk of Contamination & Containment in co...Aseptic Process Sampling to address Risk of Contamination & Containment in co...
Aseptic Process Sampling to address Risk of Contamination & Containment in co...
 
Bioburden control: Strategies to address bioburden control in downstream proc...
Bioburden control: Strategies to address bioburden control in downstream proc...Bioburden control: Strategies to address bioburden control in downstream proc...
Bioburden control: Strategies to address bioburden control in downstream proc...
 
Facility Intensification and Cost Reduction using an Integrated Buffer Delive...
Facility Intensification and Cost Reduction using an Integrated Buffer Delive...Facility Intensification and Cost Reduction using an Integrated Buffer Delive...
Facility Intensification and Cost Reduction using an Integrated Buffer Delive...
 
PVA for sustained release: theory and practice
PVA for sustained release: theory and practicePVA for sustained release: theory and practice
PVA for sustained release: theory and practice
 
A Holistic Approach to Upstream Viral Safety
A Holistic Approach to Upstream Viral SafetyA Holistic Approach to Upstream Viral Safety
A Holistic Approach to Upstream Viral Safety
 
Process Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyProcess Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene Therapy
 
Extractables profiles for chromatography resins - adapted approach of upcomin...
Extractables profiles for chromatography resins - adapted approach of upcomin...Extractables profiles for chromatography resins - adapted approach of upcomin...
Extractables profiles for chromatography resins - adapted approach of upcomin...
 
Hot melt extrusion with PVA: A new opportunity for challenging APIs
Hot melt extrusion with PVA: A new opportunity for challenging APIs Hot melt extrusion with PVA: A new opportunity for challenging APIs
Hot melt extrusion with PVA: A new opportunity for challenging APIs
 
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...
 
Challenges using Multiple Single-use Systems: Functionality versus Extractabl...
Challenges using Multiple Single-use Systems: Functionality versus Extractabl...Challenges using Multiple Single-use Systems: Functionality versus Extractabl...
Challenges using Multiple Single-use Systems: Functionality versus Extractabl...
 

Similar to Using Single-use Technology to Overcome the Challenges of ADC Processing

AcylicsForTheFuture
AcylicsForTheFutureAcylicsForTheFuture
AcylicsForTheFuture
Joe Stuart
 
Hecht Brochure Pharma (BeNeLux) containment
Hecht Brochure Pharma (BeNeLux) containmentHecht Brochure Pharma (BeNeLux) containment
Hecht Brochure Pharma (BeNeLux) containment
https://plantpartner.nl/
 
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
Merck Life Sciences
 
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
MilliporeSigma
 
C21 2 good practice overview_final-web
C21 2 good practice overview_final-webC21 2 good practice overview_final-web
C21 2 good practice overview_final-web
Dir Jan
 

Similar to Using Single-use Technology to Overcome the Challenges of ADC Processing (20)

ADC Production - A Journey made safer and faster
ADC Production - A Journey made safer and fasterADC Production - A Journey made safer and faster
ADC Production - A Journey made safer and faster
 
ADC Production - A Journey made safer and faster
ADC Production - A Journey made safer and fasterADC Production - A Journey made safer and faster
ADC Production - A Journey made safer and faster
 
Tackling the challenges of single-use manufacturing for ADCs
Tackling the challenges of single-use manufacturing for ADCsTackling the challenges of single-use manufacturing for ADCs
Tackling the challenges of single-use manufacturing for ADCs
 
Tackling the challenges of single-use manufacturing for ADCs
Tackling the challenges of single-use manufacturing for ADCsTackling the challenges of single-use manufacturing for ADCs
Tackling the challenges of single-use manufacturing for ADCs
 
STANDARDIZATION AND PARTNERSHIP
STANDARDIZATION AND PARTNERSHIPSTANDARDIZATION AND PARTNERSHIP
STANDARDIZATION AND PARTNERSHIP
 
Kurita Europe company profile
Kurita Europe company profileKurita Europe company profile
Kurita Europe company profile
 
AcylicsForTheFuture
AcylicsForTheFutureAcylicsForTheFuture
AcylicsForTheFuture
 
Single-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed ProcessingSingle-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed Processing
 
Single-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed ProcessingSingle-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed Processing
 
Hecht Brochure Pharma (BeNeLux) containment
Hecht Brochure Pharma (BeNeLux) containmentHecht Brochure Pharma (BeNeLux) containment
Hecht Brochure Pharma (BeNeLux) containment
 
Comm sk gsg a to d iss 10
Comm sk gsg a to d iss 10Comm sk gsg a to d iss 10
Comm sk gsg a to d iss 10
 
Reducing Contamination Risk and Improving Product Recovery During Final Steri...
Reducing Contamination Risk and Improving Product Recovery During Final Steri...Reducing Contamination Risk and Improving Product Recovery During Final Steri...
Reducing Contamination Risk and Improving Product Recovery During Final Steri...
 
Bayer, suspend flexx presentation
Bayer, suspend flexx presentationBayer, suspend flexx presentation
Bayer, suspend flexx presentation
 
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
 
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
 
C21 2 good practice overview_final-web
C21 2 good practice overview_final-webC21 2 good practice overview_final-web
C21 2 good practice overview_final-web
 
Presentacion Mobiwat
Presentacion MobiwatPresentacion Mobiwat
Presentacion Mobiwat
 
Ultrapure Water Purification System
Ultrapure Water Purification SystemUltrapure Water Purification System
Ultrapure Water Purification System
 
Sample Management Presentation
Sample Management PresentationSample Management Presentation
Sample Management Presentation
 
MEMBOARD : A SMART SOLUTION FOR THE MANAGEMENT OF MEMBRANE FILTRATION FACILITIES
MEMBOARD : A SMART SOLUTION FOR THE MANAGEMENT OF MEMBRANE FILTRATION FACILITIESMEMBOARD : A SMART SOLUTION FOR THE MANAGEMENT OF MEMBRANE FILTRATION FACILITIES
MEMBOARD : A SMART SOLUTION FOR THE MANAGEMENT OF MEMBRANE FILTRATION FACILITIES
 

More from MilliporeSigma

Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...
MilliporeSigma
 
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
MilliporeSigma
 
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapiesIdentity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapies
MilliporeSigma
 
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
MilliporeSigma
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
MilliporeSigma
 
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...
MilliporeSigma
 
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
MilliporeSigma
 

More from MilliporeSigma (20)

Launch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide AlternativeLaunch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide Alternative
 
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
 
Use of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein PurificationUse of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein Purification
 
Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...
 
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
 
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
 
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
 
The Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical AuditsThe Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical Audits
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
 
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapiesIdentity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapies
 
Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...
 
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
 
How does the ICH Q5A revision impact viral safety strategies for biologics?
How does the ICH Q5A revision impact viral safety strategies for biologics?How does the ICH Q5A revision impact viral safety strategies for biologics?
How does the ICH Q5A revision impact viral safety strategies for biologics?
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
 
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...
 
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use SystemsRisk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
 
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
 
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
 
The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...
 
How to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC TherapiesHow to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC Therapies
 

Recently uploaded

INTERNATIONAL HEALTH AGENCIES BY ANUSHRI SRIVASTAV.pptx
INTERNATIONAL HEALTH AGENCIES BY ANUSHRI SRIVASTAV.pptxINTERNATIONAL HEALTH AGENCIES BY ANUSHRI SRIVASTAV.pptx
INTERNATIONAL HEALTH AGENCIES BY ANUSHRI SRIVASTAV.pptx
AnushriSrivastav
 
ITM HOSPITAL The hospital has also been recognised as the best emerging hosp...
ITM  HOSPITAL The hospital has also been recognised as the best emerging hosp...ITM  HOSPITAL The hospital has also been recognised as the best emerging hosp...
ITM HOSPITAL The hospital has also been recognised as the best emerging hosp...
jvomprakash
 
obat aborsi Sragen wa 082223595321 jual obat aborsi cytotec asli di Sragen
obat aborsi Sragen wa 082223595321 jual obat aborsi cytotec asli di Sragenobat aborsi Sragen wa 082223595321 jual obat aborsi cytotec asli di Sragen
obat aborsi Sragen wa 082223595321 jual obat aborsi cytotec asli di Sragen
siskavia171
 
Cytotec 200mcg tab in Riyadh (+919101817206// Get Abortion Pills in Saudi Arabia
Cytotec 200mcg tab in Riyadh (+919101817206// Get Abortion Pills in Saudi ArabiaCytotec 200mcg tab in Riyadh (+919101817206// Get Abortion Pills in Saudi Arabia
Cytotec 200mcg tab in Riyadh (+919101817206// Get Abortion Pills in Saudi Arabia
jaanualu31
 
Abortion pills in Abu Dhabi ௵+918133066128௹Un_wandted Pregnancy Kit in Dubai UAE
Abortion pills in Abu Dhabi ௵+918133066128௹Un_wandted Pregnancy Kit in Dubai UAEAbortion pills in Abu Dhabi ௵+918133066128௹Un_wandted Pregnancy Kit in Dubai UAE
Abortion pills in Abu Dhabi ௵+918133066128௹Un_wandted Pregnancy Kit in Dubai UAE
Abortion pills in Kuwait Cytotec pills in Kuwait
 
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdfTortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Dr. Afreen Nasir
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
mcsprintern12024
 

Recently uploaded (20)

Unlock the Secrets to Optimizing Ambulatory Operations Efficiency and Change ...
Unlock the Secrets to Optimizing Ambulatory Operations Efficiency and Change ...Unlock the Secrets to Optimizing Ambulatory Operations Efficiency and Change ...
Unlock the Secrets to Optimizing Ambulatory Operations Efficiency and Change ...
 
Famous Indian Vedic Astrologer | Best Astrological Solutions UK
Famous Indian Vedic Astrologer | Best Astrological Solutions UKFamous Indian Vedic Astrologer | Best Astrological Solutions UK
Famous Indian Vedic Astrologer | Best Astrological Solutions UK
 
LTM Session-8-Practices-that-assist-BF..ppt
LTM Session-8-Practices-that-assist-BF..pptLTM Session-8-Practices-that-assist-BF..ppt
LTM Session-8-Practices-that-assist-BF..ppt
 
GENETICS and KIDNEY DISEASES /
GENETICS and KIDNEY DISEASES            /GENETICS and KIDNEY DISEASES            /
GENETICS and KIDNEY DISEASES /
 
Session-3-Promoting-Breastfeeding-During-Pregnancy.ppt
Session-3-Promoting-Breastfeeding-During-Pregnancy.pptSession-3-Promoting-Breastfeeding-During-Pregnancy.ppt
Session-3-Promoting-Breastfeeding-During-Pregnancy.ppt
 
Leading large scale change: a life at the interface between theory and practice
Leading large scale change: a life at the interface between theory and practiceLeading large scale change: a life at the interface between theory and practice
Leading large scale change: a life at the interface between theory and practice
 
INTERNATIONAL HEALTH AGENCIES BY ANUSHRI SRIVASTAV.pptx
INTERNATIONAL HEALTH AGENCIES BY ANUSHRI SRIVASTAV.pptxINTERNATIONAL HEALTH AGENCIES BY ANUSHRI SRIVASTAV.pptx
INTERNATIONAL HEALTH AGENCIES BY ANUSHRI SRIVASTAV.pptx
 
Session-1-MBFHI-A-part-of-the-Global-Strategy.ppt
Session-1-MBFHI-A-part-of-the-Global-Strategy.pptSession-1-MBFHI-A-part-of-the-Global-Strategy.ppt
Session-1-MBFHI-A-part-of-the-Global-Strategy.ppt
 
ITM HOSPITAL The hospital has also been recognised as the best emerging hosp...
ITM  HOSPITAL The hospital has also been recognised as the best emerging hosp...ITM  HOSPITAL The hospital has also been recognised as the best emerging hosp...
ITM HOSPITAL The hospital has also been recognised as the best emerging hosp...
 
Etiology for RRT and Code Blue Workshop.
Etiology for RRT and Code Blue Workshop.Etiology for RRT and Code Blue Workshop.
Etiology for RRT and Code Blue Workshop.
 
Lactation Mraining Management Session-2-Comm-Building-Conf.ppt
Lactation Mraining Management  Session-2-Comm-Building-Conf.pptLactation Mraining Management  Session-2-Comm-Building-Conf.ppt
Lactation Mraining Management Session-2-Comm-Building-Conf.ppt
 
obat aborsi Sragen wa 082223595321 jual obat aborsi cytotec asli di Sragen
obat aborsi Sragen wa 082223595321 jual obat aborsi cytotec asli di Sragenobat aborsi Sragen wa 082223595321 jual obat aborsi cytotec asli di Sragen
obat aborsi Sragen wa 082223595321 jual obat aborsi cytotec asli di Sragen
 
Technology transfer documentation and strategies
Technology transfer documentation and strategiesTechnology transfer documentation and strategies
Technology transfer documentation and strategies
 
Cytotec 200mcg tab in Riyadh (+919101817206// Get Abortion Pills in Saudi Arabia
Cytotec 200mcg tab in Riyadh (+919101817206// Get Abortion Pills in Saudi ArabiaCytotec 200mcg tab in Riyadh (+919101817206// Get Abortion Pills in Saudi Arabia
Cytotec 200mcg tab in Riyadh (+919101817206// Get Abortion Pills in Saudi Arabia
 
Abortion pills in Abu Dhabi ௵+918133066128௹Un_wandted Pregnancy Kit in Dubai UAE
Abortion pills in Abu Dhabi ௵+918133066128௹Un_wandted Pregnancy Kit in Dubai UAEAbortion pills in Abu Dhabi ௵+918133066128௹Un_wandted Pregnancy Kit in Dubai UAE
Abortion pills in Abu Dhabi ௵+918133066128௹Un_wandted Pregnancy Kit in Dubai UAE
 
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdfTortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
 
I urgently need a love spell caster to bring back my ex. +27834335081 How can...
I urgently need a love spell caster to bring back my ex. +27834335081 How can...I urgently need a love spell caster to bring back my ex. +27834335081 How can...
I urgently need a love spell caster to bring back my ex. +27834335081 How can...
 
Navigating Conflict in PE Using Strengths-Based Approaches
Navigating Conflict in PE Using Strengths-Based ApproachesNavigating Conflict in PE Using Strengths-Based Approaches
Navigating Conflict in PE Using Strengths-Based Approaches
 
An overview of Muir Wood Adolescent and Family Services teen treatment progra...
An overview of Muir Wood Adolescent and Family Services teen treatment progra...An overview of Muir Wood Adolescent and Family Services teen treatment progra...
An overview of Muir Wood Adolescent and Family Services teen treatment progra...
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 

Using Single-use Technology to Overcome the Challenges of ADC Processing

  • 1. Merck KGaA Darmstadt, Germany Mary Robinette and Elizabeth Goodrich September 26, 2019 Using Single-use Technology to Overcome the Challenges of ADC Processing
  • 2. 2 Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 2019 The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada.
  • 3. Agenda 01 The Case for Using Single-use Equipment in ADC Processes 02 Single-use Component Compatibility Testing 03 ADC Single-use cGMP Production - Lessons Learned 04 Conclusions 3
  • 4. Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 2019 The Case for Single-use in ADC Processes 01
  • 5. 5 Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 2019 Single-use Technology to Streamline Bioprocessing Speed Safety Process Economics Flexibility  Faster product changeover  Accelerated time to clinic or market  Faster implementation  Eliminates cleaning Validation  Reduced bioburden risks  Reduced cross- contamination risks  Reduced operator and environment exposure  Adaptability to changing process needs  Multi-product manufacturing facilities  Scalable and movable platforms  Lower cost: reduced water/caustics, utilities, equipment downtime, and unproductive labor  Compact footprint  Lower investment
  • 6. 6 Applicability of Single-use Technology for ADCs  Process capability for ADC processes  Compatibility/Extractable Studies including ADC solvents  Single Use Assembly Testing − Leak testing − Class VI USP  Product Specific Testing − BioReliance® Extractable and Leachable Validation Services Solvent Component Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 2019
  • 7. Single-use ADC Process 7 Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 20197 Reaction Mobius® Mix 10-1000L UF/DF Mobius® FlexReady TF2, TF3 2-10m2 Chromatography Mobius® FlexReady 0.1 – 8LPM Formulation/ Filtration Mobius® Mix and Filters 10-1000L Filtration Opticap® Filter with Millipore Express® SHC membrane UF/DF Mobius® FlexReady TF2,TF3 0.5-10m2 Solvent Component
  • 8. 8 Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 2019 Solvent Compatibility Considerations  Solvent composition  Product contact components  Performance testing − Visual inspection for leaks and physical changes − Functionality testing − Sterile filters – verify microbial retention − Extractables ADC Single-use Process – Solvent Compatibility T Mobius® FlexReady Solution with Smart Flexware® Assemblies
  • 9. Common ADC Process Solvents  Drug charge to reactor: − 100% DMSO (Dimethyl Sulfoxide) − 100% DMAc (Dimethyl Acetamide)  Reaction/Purification composition − up to 20% DMSO − up to 20% DMAc ADC Single-use Process – Solvent Composition Mobius® Single-use Jacketed Mix 100 L 9 Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 2019
  • 10. ADC Single-use Reactor – Solvent Compatibility Mix bag components  Bag film  Ports  Mixer  Tubing  Sampling valve Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201910 Mixer Sampling Mobius® MyWay 50L PureFlex™ Mobius® MIX Bag Ports Film Example Mix Bag Components PureFlex™ Film Risk assess component exposure to 100% solvent
  • 11. Flow path assembly components  Pump  Valves  Instrumentation  Mix bag  Sampling ADC Purification Equipment – Solvent Compatibility Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201911 Recovery Line To Transfer Pump Smart Flexware® Assembly for TFF 100L Single-use Feed Container Assembly Filtrate Assembly with Single-use Sensors Flow Cell Retentate Sampling Port Assembly Dow Corning® Pharma-80 Tubing, used to create bypass loop around TFF liners and cassettes Extractable Test Setup on Mobius® FlexReady Solution with Smart Flexware® Assemblies for TFF Single-use Feed Pump Assembly Test Setup on Mobius® FlexReady Solution with Smart Flexware® Assemblies for TFF
  • 12. Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 2019 Single-use Component Compatibility Testing 02
  • 13. After exposure to:  20% and 100% Dimethyl Sulfoxide (DMSO)  20% and 100% Dimethyl Acetamide (DMAc)  Water Provide understanding on compatibility of selected standard single-use assemblies and components with the solvents most commonly used in ADC processing Overview of Compatibility Testing Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201913 Evaluate functionality and extractables of:  Mobius® MIX bag made from PureFlex™ film  Opticap® XL filter with Millipore Express® SHC membrane  Mobius® FlexReady Solution with SMART Flexware® assemblies for TFF or Chromatography  Lynx® CDR and Lynx® S2S sterile connectors  Colder AseptiQuik® G sterile connectors
  • 14. PureFlex™ film  100% DMSO, 100% DMAc, RO water  24-hour soak in solvent at 40°C Post-solvent exposure:  No visual changes  No change in bag seam strength  Slight increase in film elongation at break − No negative performance impact expected − In use, bag is supported in a holder Mobius® MIX bag testing Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201914
  • 15. Millipore Express® SHC 0.5 mm / 0.2 mm PES membrane  47 mm membrane discs and 5” Opticap® XLT capsule  20% DMSO, 20% DMAc, RO water  24-hour soak in solvent at 40°C Post-solvent exposure:  No visual or physical changes  Water flow passes specification  Bubble point passes specification  Capsule maintains complete microbial retention (> 9 log reduction of B. diminuta) Millipore Express® SHC membrane and Opticap® Filter Capsule testing Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201915 ADC Processing using Millipore Express® SHC (Cat#KHGEG015FF3/Lot#C8DA57941) Bacterial Retention Test (B. diminuta;>107 CFU/cm2)
  • 16. Opticap® Filter with Millipore Express® SHC Extractables Evaluation Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201916  No pre-use flush of capsule  All identified components are from membrane manufacture or gamma irradiation  In a worse-case process scenario with low filter throughput (150 L/m2), all extractable components would be < 0.1 mg/mL in pool  Subsequent diafiltration will reduce even more Opticap® XL5 Capsule with Millipore Express® SHC Membrane Non-Volatile Extractables via HPLC-DAD/MS Opticap® XL5 Capsule with Millipore Express® SHC Membrane Semi-Volatile Extractables via DI-GC/MS Opticap® XL5 Capsule with Millipore Express® SHC Membrane Volatile Extractables via HS-GC/MS
  • 17. Flow Paths and Wetted Materials for Solvent Exposure Testing Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201917 Recovery Line To Transfer Pump Smart Flexware® Assembly for TFF 100L Single-use Feed Container Assembly Filtrate Assembly with Single-use Sensors Flow Cell Retentate Sampling Port Assembly Dow Corning® Pharma-80 Tubing, used to create bypass loop around TFF liners and cassettes Extractable Test Setup on Mobius® FlexReady Solution with Smart Flexware® Assemblies for TFF Single-use Feed Pump Assembly Lynx® Connectors Flow Loop AseptiQuik® G Flow Loop Extractable Test Setup on Mobius ® FlexReady Solution with Smart Flexware® Assemblies for TFF
  • 18. Flowpaths for Post-Exposure Functional Testing Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201918 Valve Bypass Test setup #1 Valve Bypass Test setup #2 Valve Cycling Test setup
  • 19. Metals Analysis  Only traces of sodium and calcium were detected  No metals identified are classified as elements to be considered in the risk assessment as outlined in ICH Q3D Guideline for Elemental Impurities and USP <232> Elemental Impurities Non-Volatile Organic Analysis  No compounds were detected in any system or solvent combination using LC-MS analysis. Volatile Organic Analysis  HS-GC/MS analysis for volatile organic compounds indicated no extractable peaks in any system. Semi-Volatile Organic Analysis  DI-GC/MS analysis for semi-volatile organic compounds did not identify any peaks above 0.05 mg/mL.  Results from DMAc exposure, shown on next slide, represent the highest observed levels of the three solutions which were tested. Mobius® Smart Flexware™ and Lynx® Connector Extractables Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201919
  • 20. Extractables after Exposure to 20% DMAc Smart Flexware® Assemblies and Connectors for Mobius® systems, Method: DI-GC/MS 1 Mobius® TF-2S Smart Flexware® assembly, 6L recirculation Extractables after Exposure to 20% DMAc: Direct Inject GC-MS Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201920 Extractables after Exposure to 20% DMAc Smart Flexware® Assemblies and Connectors for Mobius® systems, Method: DI-GC/MS All identified compounds are < 0.05 mg/mL 1 TF-2S Smart Flexware® Assembly, 6L recirculation 1 Lynx® CDR and 1 Lynx® S2S, 0.5L recirculation 2 AseptiQuick® G connectors, 0.5L recirculation
  • 21. Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 2019 ADC Single-use cGMP Production – Lessons Learned 03
  • 22.  Single-use system design/suitability review: end user and supplier − User requirements collaboration session − Proper selection of standard systems and options − Review options for single-use assembly custom design − Users attend supplier demonstration of single- use equipment − Outcome: optimal single use-system for application  Supplier training for production success − Single-use system hardware − Single-use assembly unpacking and installation − Key to prevent single use assembly damage ADC Single-use End-user / Supplier Collaboration for Success Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201922 Mobius® Single-use Jacketed Mixers M Lab™ Burlington, MA
  • 23. Single-use Technology Benefits - ADC Production experience Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201923 Speed Safety Process Economics Flexibility  Faster product changeover  Accelerated time to clinic or market  Faster implementation  Eliminates cleaning Validation  Reduced bioburden risks  Reduced cross-contamination risks  Reduced operator and environment exposure  Adaptability to changing process needs  Multi-product manufacturing facilities  Scalable and movable platforms  Lower cost: reduced water/caustics, utilities, equipment downtime, and unproductive labor  Compact footprint  Lower investment Reduced ADC potent waste handling/disposal
  • 24. Platform ADC process equipment  Standard automated hardware and single use flowpath assemblies − Examples: Chromatography and TFF skids, mix bags  Development of standards for custom designed single use assemblies - multiple product/process application − Examples: − Bag manifolds with pump tubing, sample bag and filter in one single use assembly − Mix bag assemblies for ADC reactor, process blending and formulation  Additional benefits − Simplified inventory − Reduce operator training/manual intervention − Reduce autoclave parts ADC Single-use - Production Experience Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201924
  • 25. Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 2019 Conclusions 04
  • 26.  Demonstrated solvent compatibility of the most commonly used ADC conjugation chemicals at conditions that exceed typical concentrations and exposure times for: − Mobius® Mix bag with PureFlex™ film − Opticap® XL filter with Millipore Express® SHC membrane − Mobius® FlexReady Solution with Smart Flexware® Assemblies for TFF or Chromatography − Mobius Lynx® CDR, Mobius Lynx® S2S Connectors and Colder AseptiQuik® G sterile connectors  After 24 Hour exposure to 20% DMSO or 20% DMAc − No leaks and no physical changes observed by visual inspection − Bags, flexware, connectors, and filters passed all functionality testing including microbial retention − PureFlex™ film maintained performance after 24-hour exposure to 100% DMSO or 100% DMAc  Extractables Profile − No peaks were identified by LC-MS or HS GC-MS for any of the solvent extractions. − Several peaks were visible using DI GC-MS. No compounds were present above 0.05 mg/mL. − No metals identified by ICP that are classified as elements to be considered in the risk assessment per ICH Q3D Guideline for Elemental Impurities and USP <232> Elemental Impurities Conclusions: Compatibility and Extractables Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201926
  • 27.  A broad range of single-use equipment is available to meet the challenging needs of ADC production.  Single-use assemblies are compatible with ADC process solutions.  Single-use supplier and end user collaboration is key for successful process application.  Single-use equipment benefits are realized in ADC production.  Use of standard and custom single-use systems allows for an ADC process equipment platform that meets multiple product/process needs. Conclusions: Single-use Application for ADC Process Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201927
  • 28. Using Single-use Technology to Overcome the Challenges of ADC Processing | 26 September 201928 Acknowledgements Compatibility and Extractables Testing Team: Dana Kinzlmaier Jessica Shea Shannon Ryan Venkata Raman Alex Chalmers Brian Callahan Shikeba Shirzay Mobius® Technical support  R&D  Applications Engineering  Bioprocessing Bio-Conjugation Center of Excellence St. Louis  Global Process & Analytical Development  ADC Production manufacturing
  • 29. Director of MSAT Applications Engineering Email: Elizabeth.Goodrich@milliporesigma.com Principal Project Engineer, API Global Engineering Email: Mary.Robinette@milliporesigma.com Elizabeth GoodrichMary Robinette The vibrant M, SAFC, Mobius, Lynx, Opticap, Millipore Express, Emprove, Flexware and PureFlex are trademarks of Merck KGaA, Darmstadt, Germany or its affiliates. All other trademarks are the property of their respective owners. Detailed information on trademarks is available via publicly accessible resources. © 2019 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved. Thank you!